These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 35576953)

  • 1. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
    Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
    Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
    Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
    Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
    GBD 2019 Europe Hepatitis B & C Collaborators
    Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis.
    Wu S; Wang J; Guo Q; Lan H; Sun Y; Ren M; Liu Y; Wang P; Wang L; Su R; Zhang J; Chen Y; Li G
    Clin Microbiol Infect; 2023 Aug; 29(8):1000-1007. PubMed ID: 36921717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global reporting of progress towards elimination of hepatitis B and hepatitis C.
    Cui F; Blach S; Manzengo Mingiedi C; Gonzalez MA; Sabry Alaama A; Mozalevskis A; Séguy N; Rewari BB; Chan PL; Le LV; Doherty M; Luhmann N; Easterbrook P; Dirac M; de Martel C; Nayagam S; Hallett TB; Vickerman P; Razavi H; Lesi O; Low-Beer D
    Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):332-342. PubMed ID: 36764320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis.
    Ahmadi Gharaei H; Fararouei M; Mirzazadeh A; Sharifnia G; Rohani-Rasaf M; Bastam D; Rahimi J; Kouhestani M; Rezaian S; Dianatinasab M
    Infect Dis Poverty; 2021 Jul; 10(1):93. PubMed ID: 34210349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Hepatitis B Collaborators
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.
    Kenfack-Momo R; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Tchatchouang S; Oyono MG; Kenfack-Zanguim J; Lontuo Fogang R; Mbongue Mikangue CA; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Taya-Fokou JB; Bowo-Ngandji A; Nkie Esemu S; Kamdem Thiomo D; Moundipa Fewou P; Ndip L; Njouom R
    PLoS One; 2022; 17(5):e0269250. PubMed ID: 35639675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study.
    Yan LB; Rao HY; Ma YJ; Bai L; Chen EQ; Du LY; Yang RF; Wei L; Tang H;
    BMJ Open; 2016 Oct; 6(10):e012016. PubMed ID: 27733412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study.
    Makuza JD; Jeong D; Binka M; Adu PA; Cua G; Yu A; Velásquez García HA; Alvarez M; Wong S; Bartlett S; Karim ME; Yoshida EM; Ramji A; Krajden M; Janjua NZ
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.
    Ou TY; Huy LD; Mayne J; Shih CL; Mai Xuan H; Thi Hong Nguyen N; Nguyen Hoai L; Thi My Bui L; Chang YM; Abdi AA; Hsu SC; Lin HJ; Huang CC
    J Infect Public Health; 2024 Jul; 17(7):102443. PubMed ID: 38838606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis.
    Vincent JP; Nyamasege C; Wang S; Madec Y; Shimakawa Y
    Front Public Health; 2022; 10():1099571. PubMed ID: 36711383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.